-
Product Insights
Mt Stuart Power Station
Mt Stuart Power Station is a thermal project located in Queensland, Australia. The project is owned by Origin Energy Ltd. The project came online in 1999. Empower your strategies with our Mt Stuart Power Station report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST-100 in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST-100 in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST-100 in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: ST-100 is...
-
Product Insights
NewTotal Artificial Heart Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
A Total Artificial Heart is a prosthetic device that is implanted into the body to replace the biological heart. GlobalData's Medical Devices sector report, “Total Artificial Heart Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Total Artificial Heart pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Total Artificial Heart report...
-
Product Insights
Myopia – Drugs In Development, 2023
Global Markets Direct’s, ‘Myopia - Drugs In Development, 2023’, provides an overview of the Myopia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myopia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Sector Analysis
United Kingdom (UK) Commercial Motor Insurance Market Trends, Competitor Dynamics and Opportunities
The gross written premium (GWP) in the UK commercial motor insurance market was valued at GBP5.65 billion in 2022. The UK commercial motor insurance market experienced a marginal decline of 0.3% in gross written premiums (GWP) in 2022 when compared to the preceding year. However, a sharp rise in premiums throughout 2023 will cause significant growth in the market. According to GlobalData forecasts, the UK commercial motor insurance market will bounce back in 2023, driven by soaring premiums due to...
-
Product Insights
Macular Edema – Drugs In Development, 2023
Global Markets Direct’s, ‘Macular Edema - Drugs In Development, 2023’, provides an overview of the Macular Edema pipeline landscape. The report provides comprehensive information on the therapeutics under development for Macular Edema, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Keratoconjunctivitis Sicca (Dry Eye) – Drugs In Development, 2023
Global Markets Direct’s, ‘Keratoconjunctivitis Sicca (Dry Eye) - Drugs In Development, 2023’, provides an overview of the Keratoconjunctivitis Sicca (Dry Eye) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Keratoconjunctivitis Sicca (Dry Eye), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...